Authors: Kuhn, J Gotting, C Schnolzer, M Kempf, T Brinkmann, T Kleesiek, K

Citation: J. Kuhn et al., First isolation of human UDP-D-xylose: Proteoglycan core protein beta-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells, J BIOL CHEM, 276(7), 2001, pp. 4940-4947

Authors: Gotting, C Kuhn, J Zahn, R Brinkmann, T Kleesiek, K

Citation: C. Gotting et al., Molecular cloning and expression of human UDP-D-xylose : proteoglycan coreprotein beta-D-xylosyltransferase and its first isoform XT-II, J MOL BIOL, 304(4), 2000, pp. 517-528

Authors: Gotting, C Kuhn, J Sollberg, S Huerkamp, C Brinkmann, T Krieg, T Kleesiek, K

Citation: C. Gotting et al., Elevated serum xylosyltransferase activity correlates with a high level ofhyaluronate in patients with systemic sclerosis, ACT DER-VEN, 80(1), 2000, pp. 60-61

Authors: Kleesiek, K Schmidt, M Gotting, C Schwenz, B Lange, S Muller-Berghaus, G Brinkmann, T Prohaska, W

Citation: K. Kleesiek et al., The 536C -> T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis, THROMB HAEM, 82(1), 1999, pp. 1-5

Authors: Gotting, C Sollberg, S Kuhn, J Weilke, C Huerkamp, C Brinkmann, T Krieg, T Kleesiek, K

Citation: C. Gotting et al., Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis, J INVES DER, 112(6), 1999, pp. 919-924